EMERALD ADVISERS, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$10,000
-95.1%
140
-89.1%
0.00%
-100.0%
Q1 2019$204,000
-45.6%
1,280
-67.3%
0.01%
-55.6%
Q4 2018$375,000
-40.9%
3,911
-12.8%
0.02%
-21.7%
Q3 2018$634,000
-11.9%
4,485
-2.5%
0.02%
-14.8%
Q2 2018$720,000
-97.1%
4,602
-97.0%
0.03%
-97.3%
Q1 2018$24,630,000
-11.4%
152,913
-9.4%
0.99%
-7.8%
Q4 2017$27,801,000
+489.6%
168,785
+123.0%
1.07%
+457.8%
Q3 2017$4,715,000
-67.6%
75,679
-58.6%
0.19%
-68.4%
Q2 2017$14,559,000
+41.3%
182,804
+26.1%
0.61%
+43.7%
Q1 2017$10,306,000145,0180.42%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders